Deerfield Private Design Fund IV, L.P.
CIK 1680307
Transactions on file
13
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+25.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | Disp. | 3,444 | $427.1K | -0.0% | open → |
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | U | 5,146 | $638.1K | -0.0% | open → |
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | U | 5,146 | $638.1K | -0.0% | open → |
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | Disp. | 650,000 | $80.60M | -0.0% | open → |
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | Disp. | 8,299,225 | $1.03B | -0.0% | open → |
| 2026-07-17 | 2026-07-15 | NUVL Nuvalent, Inc. | Director10%Other | Disp. | 8,299,225 | $1.03B | -0.0% | open → |
| 2025-11-24 | 2025-11-24 | NUVL Nuvalent, Inc. | Director10%Other | Sale | 371,287 | $35.44M | +29.9% | open → |
| 2025-11-24 | 2025-11-24 | NUVL Nuvalent, Inc. | Director10%Other | Sale | 371,287 | $35.44M | +29.9% | open → |
| 2025-07-01 | 2025-06-27 | SPRY ARS Pharmaceuticals, Inc. | 10% | Sale | 370,075 | $6.83M | -67.8% | open → |
| 2025-07-01 | 2025-06-27 | SPRY ARS Pharmaceuticals, Inc. | 10% | Sale | 370,074 | $6.83M | -67.8% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 2,599,932 | $8.32M | +25.0% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 3,387,539 | $10.84M | +25.0% | open → |
| 2025-08-04 | 2025-07-31 | LRMR Larimar Therapeutics, Inc. | Director10%Other | Buy | 3,387,529 | $10.84M | +25.0% | open → |
